---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-006000"
form_type: "8-K"
ticker: "SMTI"
cik: "0000714256"
company_name: "Sanara MedTech Inc."
filed_at: "2023-02-24T23:59:59+00:00"
generated_at: "2026-06-19T01:02:15.269751+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Sanara MedTech enters $75M at-the-market equity offering agreement with Cantor Fitzgerald

## Summary
- Up to $75M of common stock may be sold from time to time through Cantor Fitzgerald & Co.
- Cantor receives a 3.0% commission on gross proceeds from each sale.
- Sales are at-the-market offerings under Rule 415(a)(4); no obligation to sell any shares.
- Agreement may be suspended or terminated by either party upon notice.
- Shares are registered under existing S-3 shelf registration statement (File No. 333-251652).

## SEC filing metadata
- accession: 0001493152-23-006000
- form_type: 8-K
- ticker: SMTI
- cik: 0000714256
- company_name: Sanara MedTech Inc.
- filed_at: 2023-02-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/714256/000149315223006000/0001493152-23-006000-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/714256/000149315223006000/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-006000
- JSON: https://secwatch.observer/filing/0001493152-23-006000.json
- Plain text: https://secwatch.observer/filing/0001493152-23-006000.txt

## Key facts
- Material Agreements
  Sanara MedTech Inc. entered into Sales Agreement with Cantor Fitzgerald & Co. valued at up to $75,000,000 (effective 2023-02-24).
  - Action: entry
  - Agreement: atm program
  - Counterparty: Cantor Fitzgerald & Co.
  - Value: up to $75,000,000
  - Effective: 2023-02-24
  source text: On February 24, 2023, Sanara MedTech Inc., a Texas corporation (the “Company”), entered into a Controlled Equity Offering SM Sales Agreement (the “Sales Agreement”) with Cantor Fitzgerald & Co., as sales agent (“Cantor”), pursuant to which the Company may offer and sell from time to time, to or through Cantor, shares of the Company’s common stock, par value $0.001 per share, having an aggregate offering price of up to $75,000,000 (the “Shares”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/714256/000149315223006000/0001493152-23-006000-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.